TABLE 3

Biodistribution of 18F-FCH in Human Subjects at 10–55 Minutes After Injection

ParameterFemaleMale
Subjects
n57
 Age (y)44 ± 774 ± 8
 Body weight (kg)70.8 ± 22.681.4 ± 14.0
Tissue (% dose/g × 103)
 Myocardium2.52 ± 1.061.65 ± 0.51
 Blood1.62 ± 0.770.84 ± 0.28
 Skin0.36 ± 0.120.32 ± 0.08
 Skeletal muscle0.70 ± 0.270.66 ± 0.27
 Lung1.25 ± 0.441.36 ± 1.21
 Normal breast0.91 ± 0.37
 Liver13.52 ± 4.699.42 ± 1.90
 Renal cortex24.70 ± 13.8514.95 ± 6.06
 Intestine2.22 ± 1.121.46 ± 0.85
 Thyroid2.83 ± 1.121.70 ± 0.38
 Salivary gland6.23 ± 3.263.47 ± 1.52
 Spleen7.84 ± 2.615.54 ± 2.46
 Normal bone1.17 ± 0.580.70 ± 0.23
 Urine6.34 ± 2.508.88 ± 4.36
Organ (% dose/organ)
 Spleen2.97 ± 3.461.35 ± 0.75
 Liver14.21 ± 0.8413.71 ± 2.63
 Left kidney4.68 ± 1.444.48 ± 3.34
 Right kidney4.44 ± 1.253.70 ± 1.90
 Urinary bladder4.88 ± 4.791.88 ± 1.58